🚀 Dreaming of a career where you can make a difference? Discover the endless possibilities at NIAID with our #recruitment video. Whether you’re passionate about science, administration, or innovation, there is a place for you. Learn more from some of the dedicated public servants who make NIAID a great place to work: https://lnkd.in/e-sD2kX5 #PSRW #NIAIDCareers
National Institute of Allergy and Infectious Diseases (NIAID)
Government Administration
Rockville, Maryland 42,668 followers
Join NIAID and make a difference!
About us
This is the official LinkedIn account for the National Institute of Allergy and Infectious Diseases (NIAID). NIAID conducts and supports basic and applied research to better understand, treat, and ultimately prevent infectious, immunologic, and allergic diseases. For more than 60 years, NIAID research has led to new therapies, vaccines, diagnostic tests, and other technologies that have improved the health of millions of people in the United States and around the world. Posted comments and images do not necessarily represent the views of NIAID, NIH. Comment Policy: www.niaid.nih.gov/global/comment-policy Privacy Policy: www.niaid.nih.gov/privacy Website: www.niaid.nih.gov
- Website
-
http://www.niaid.nih.gov
External link for National Institute of Allergy and Infectious Diseases (NIAID)
- Industry
- Government Administration
- Company size
- 1,001-5,000 employees
- Headquarters
- Rockville, Maryland
- Type
- Government Agency
Locations
-
Primary
9000 Rockville Pike
Rockville, Maryland 20892, US
Employees at National Institute of Allergy and Infectious Diseases (NIAID)
-
Gail Potter
Deputy Section Chief, Clinical Trials Research Section, at National Institute of Allergy and Infectious Diseases (NIAID)
-
Rodolfo Alarcon
Program Officer at National Institutes of Health/National Institute of Allergy and Infectious Diseases
-
Dave Chen
Senior Visualization Scientist at National Institute of Allergy and Infectious Diseases (NIAID)
-
Michael Mullins
Updates
-
The Office of Data Science and Emerging Technologies is working to make NIAID’s #InfectiousDisease data easier to find and reuse. Learn how the project aims to promote data reuse, accelerate scientific discovery, and enable #AI and ML in biomedical research: https://go.nih.gov/RdBAIl1 #DataScience
-
In the June 5, 2024 NIAID Funding News, explore a catalog of past and upcoming NIH funding webinars. Check out new initiatives on HIV service delivery and durable HIV vaccine responses. Share feedback on clinical research terminology and strategic planning for sexual and gender minority health research. Learn how to determine the earliest start date for your application’s research project. Plus, find our answers to reader questions about Select Aims and the next NIH Advisory Committee to the Director meeting. Learn more at https://go.nih.gov/1Upnk8U
-
June 5 marks #HIV Long-Term Survivors Awareness Day. NIAID joins its partners to honor the lives of people over the age of 50 years living with HIV. #NIH continues to support research that centers the needs and journeys of older adults with HIV. Learn more: https://lnkd.in/dmnUTnR #HLTSAD
-
NIAID’s new H5N1 influenza research agenda, which builds on the Institute’s longstanding influenza research efforts, focuses on four key objectives: increasing understanding of the biology of H5N1 viruses and the factors that influence their ability to transmit and cause disease; developing and evaluating prevention strategies; advancing existing and novel treatments; and supporting strategies for detecting H5N1 virus. Learn more: https://go.nih.gov/YNJ4wO2
-
CDC published clinical guidelines on the use of doxycycline post-exposure prophylaxis (#DoxyPEP) for bacterial #STIprevention, based in part on evidence from #NIAID-supported research. Learn more: https://lnkd.in/evg5uG4z.
Centers for Disease Control and Prevention on LinkedIn: CDC published clinical guidelines on counseling patients regarding...
linkedin.com
-
🔬 The Laboratory of Bacteriology at #NIAID seeks an outstanding scientist to serve as a tenure-track investigator. The ideal candidate will have expertise with C. burnetii host-pathogen interactions and be expected to develop a vigorous, independent research program on the biology and pathogenesis of C. burnetii infection. The laboratory aims to identify novel or improved strategies to control bacterial diseases, including developing diagnostics, vaccines, and therapeutics. Applications will be reviewed starting 7/15 until the position is filled. Learn more and #ApplyNow at https://go.nih.gov/6zK5ZPO #JobOpening #NIAIDCareers
Tenure-Track Investigator – Laboratory of Bacteriology
niaid.nih.gov
-
📢 Applications close soon for the scientific information analyst position in the Office of Communications and Government Relations. #ApplyNow at https://go.nih.gov/iRFGey1 #NIAIDCareers #JobOpening
The Legislative Affairs and Correspondence Management Branch in the Office of Communications and Government Relations (OCGR) at #NIAID seeks a highly skilled individual with the ability to conduct analyses of scientific programs and policies for a scientific information analyst position. OCGR values coordination across all NIAID Divisions and NIH – working together as a team to provide support to accomplish NIAID’s scientific mission. Applications open 6/03 and close 6/07. Learn more about the position at https://go.nih.gov/iRFGey1 #NIAIDCareers #NIH
Scientific Information Analyst
niaid.nih.gov
-
An HIV drug that suppresses the activity of the CCR5 receptor—a collection of proteins on the surface of certain immune cells—was associated with better renal function in kidney transplant recipients with HIV compared to people who took a placebo in a randomized trial. According to the authors, these findings warrant further exploration of the benefit of CCR5 antagonists in all kidney transplant recipients regardless of HIV status. The findings of the NIAID-sponsored trial were presented today at the 2024 American Transplant Congress in Philadelphia. Learn more: https://go.nih.gov/9QcoGAt #ATC2024Philly #CCR5 #transplantation #NIAID The National Institutes of Health University of Alabama at Birmingham Emmes Mount Sinai Health System The Johns Hopkins University Emory University Northwestern University University of Pennsylvania University of Maryland, Baltimore (UMB) UCLA
-
The #NIAID-supported HIV Prevention Trials Network launched two clinical trials to examine lenacapavir, a novel long-acting form of HIV pre-exposure prophylaxis administered every six months, in cisgender women and people who inject drugs. The trials complement ongoing large efficacy studies and are intended to provide insights on how these two priority populations experience lenacapavir-based #HIV #PrEP. The studies are sponsored and funded by Gilead Sciences Learn more: https://go.nih.gov/vioHjdO The National Institute on Drug Abuse (NIDA)